Numerical tests show that the present method compares advantageously with other similar methodologies using purely global expansions.
Both repeatability of the amperometric measurements, reproducibility with different biosensors, lifetime and storage ability show a good analytical performance, which compares advantageously with previous GOx CNT biosensor designs.
The amperometric NADH detection at +300 mV provided fast responses, a range of linearity between 5.0 × 10−7 and 2.0 × 10−5 mol l−1, and a detection limit of 1.7 × 10−7 mol l−1, which compares advantageously with those reported for other NADH CNT-based amperometric sensors.
Our results clearly show the potential of SNP arrays in improving the diagnostic rate in patients with ID/DD, without unnecessarily burdening the workload, and compare advantageously to these reports.
Yet, the specific stiffness of this carbon origami and its capability to transfer load compare advantageously to other lightweight cellular materials such as carbon nanotube foams, graphene elastomers, metallic microlattices, silica aerogel, and carbon foams.
In addition to the high field enhancement factor, the local electrical field at the tip of the g-MWCNTs was calculated and advantageously compared with already reported values meaning that this unique structure is well suited for field emission purposes.
Both repeatability of the ethanol amperometric measurements, reproducibility with different biosensors, lifetime and storage ability can be, in general, advantageously compared with other ADH CNTs biosensors.
The performance of the immunosensor is advantageously compared with that provided with immunosensors prepared by grafting SPCE with p-phenylendiamine (H2N-Phe-SPCE) and attaching AuNPs by immersion into an AuNPs suspension or by electrochemical deposition, as well as with immunosensors constructed using commercial AuNPs-modified SPCEs.
It is noteworthy that previous MSN reports studying rod-like particles in a biological setting have also been fluorescently labeled according to similar protocols, so our S-MSP1 and NR-MSP results can advantageously be compared to those.
Using our model, we were able to determine clinically relevant dosing regimens that advantageously reduce the number of rhG-CSF administrations compared to original studies while significantly improving the neutropenia status.
